Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

Part of paid clinical trials in Glendale, Arizona.

Sponsor
Avisi Technologies Inc.
Study ID
NCT07220876
Status
Recruiting
Apply to this trial

Conditions

  • Open Angle Glaucoma (OAG)

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • VisiPlate Glaucoma Implant — DEVICE
    Implant (micro-shunt) for glaucoma patients

Study Details

A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial

Key Dates

Start date
Nov 7, 2025
Status verified
Oct 2025
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
165 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment Arm

Primary Outcome Measure

Proportion of subjects (eyes) achieving a ≥ 20% reduction in mean diurnal intraocular pressure [ Time Frame: 12 Months ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Arizona Advanced Eye ResearchGlendaleArizona85306-
Sacramento Eye ConsultantsSacramentoCalifornia95815-
ICON Eye CareGrand JunctionColorado81501-
Mile High Eye InstituteSheridanColorado80226-
Cleveland Clinic- Cole Eye InstituteClevelandOhio44195-
Scheie Eye InstitutePhiladelphiaPennsylvania19104-
Wills Eye HospitalPhiladelphiaPennsylvania19107-
Glaucoma Associates of TexasDallasTexas75231-
University of Texas SouthwesternDallasTexas75390-
The Eye Centers of Racine & KenoshaKenoshaWisconsin53142-

Find similar trials in Glendale, AZ

By research site
Arizona Advanced Eye Research· Glendale, AZSacramento Eye Consultants· Sacramento, CAICON Eye Care· Grand Junction, COMile High Eye Institute· Sheridan, COCleveland Clinic- Cole Eye Institute· Cleveland, OHScheie Eye Institute· Philadelphia, PA

Related Studies